TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial.

Cristina Saura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.